NMC notifies the Establishment of Medical College Regulations, (Amendment), 2022
The amendment revises the “Qualifying Criteria” for establishing a medical college. It states that the requirement of ‘fully functional hospital for a minimum period of 2 years’ shall not apply to Universities or deemed to be universities who meet prescribed conditions.
UGC invites Feedback from stakeholders on draft guidelines for Training of Faculty on “Indian Knowledge System (IKS)”
These Guidelines were formulated in pursuance of the National Education Policy (NEP-2020). NEP 2020 lays special emphasis on the promotion of Indian Languages, Arts and Culture. Hence the Guidelines are intended to facilitate a seamless integration of Indian traditional knowledge with modern subjects.
The PCI issues notice for Effective Management of the Appeal Process for the 2022- 23 Academic Session
The Pharmacy Council of India (PCI) has issued a notice of the decisions taken by its 384th Executive Committee. The notice elucidates that the decisions are being reflected on the Council’s website. All institutions seeking to appeal the committee’s decision shall submit compliance or representation on or before 21st December, 2022.
NMC Invites Comments on the proposed draft for inclusion of Aadhar Enabled Biometric Attendance System (AEBAS) in Medical Colleges
The proposed amendment seeks to compulsorily implement an Aadhar Enabled Biometric Attendance System (AEBAS) of National Information Centre (NIC). It will be applicable to faculties, tutors, demonstrators and senior residents. The propsed amendment also states that in the absence of AEBAS, renewals, recognition or continuation thereof, increase in seats, establishment of new medical colleges or new PG course will not be permitted.
NMC’s expert committee publishes recommendations on administration of Stem Cell Treatment for Autism Spectrum Disorder
ASD is a chronic condition with onset in early childhood, with core symptoms that often persist throughout the lifespan. However, its manifestations and severity may vary from person to person, and with age. Diagnosis is based on meticulous history, careful clinical evaluation by an expert supplemented by standardised checklists, rating scales and interviews. There is no “specific test” or physical investigation to diagnose ASD. Early diagnosis is imperative for developing an early intervention strategy in ASD.
Insurance Regulatory and Development Authority of India (Regulatory Sandbox) (Amendment) Regulations, 2022
The objectives of these Regulations are to amend the Insurance Regulatory and Development Authority of India (Regulatory Sandbox) Regulations, 2019 to increase the experimental period of the Regulatory Sandbox from existing six (6) months to up to 36 months.
Insurance Regulatory and Development Authority of India (Registration of Indian Insurance Companies) Regulations, 2022
As per the regulation, no company or co-operative society shall be incorporated in India with a name that contains words ‘insurance’ or ‘assurance’ or ‘reinsurance’ without obtaining a No-objection Certificate from the Authority.
CBIC extends the due date for filing GSTR 1
The time limit for furnishing the details of outward supplies in FORM GSTR-1 for the tax period November 2022, for the registered persons required to furnish monthly return whose principal place of business is in the districts of Chennai, Tiruvallur, Chengalpattu, Kanchipuram, Tiruvannamalai, Ranipet, Vellore, Villupuram, Cuddalore, Thiruvarur, Nagapattinam, Mayiladuthurai and Thanjavur in the State of Tamil Nadu, shall be extended till the thirteenth day of the month succeeding the said tax period.
Food Safety and Standards (Advertising and Claims) Second Amendment Regulations, 2022
Where the meaning of a trademark, brand name, or fancy name containing adjectives such as “natural”, “fresh”, “pure”, “original”, “traditional”, “authentic”, “genuine”, “real”, appearing in the labeling, presentation or advertising of a food is such that it is likely to mislead the consumer as to the nature of the food, in such cases a disclaimer shall be mentioned prominently on the front of the pack of the label.
